{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:28:34Z","timestamp":1773959314794,"version":"3.50.1"},"reference-count":26,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Fengtai District Health System Research Project","award":["Grant No. 2023-42"],"award-info":[{"award-number":["Grant No. 2023-42"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,6,27]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Overactive bladder (OAB) is a common condition, affecting approximately one-fifth to one-sixth of the world\u2019s population. The American Urological Association and the Society of Urodynamics, Female Pelvic Medicine and Genitourinary Reconstruction guidelines recommend sacral neuromodulation (SNM) as third-line treatment. Although SNM can relieve the symptoms of refractory OAB, several factors, including high cost and the high incidence of adverse effects, limit its large-scale clinical use. Moreover, patient acceptance is low. Acupuncture is an alternative approach for treating OAB that is minimally invasive and has few side effects. Clinical studies have shown that it can reduce the number of episodes of urination and urgent urination within 24 hours and improve the quality of life. However, clinical evidence on the effectiveness of electroacupuncture for treating refractory OAB is limited.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>The primary objective of this study<\/jats:title>\n                  <jats:p>Is to assess the short-term effectiveness of electroacupuncture for improving the symptoms and quality of life of women with refractory OAB and to observe its long-term effects. A secondary objective is to assess whether electroacupuncture is more effective than conventional acupuncture for treating patients with refractory OAB.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>The study is designed as a two-arm, parallel, participant-blinded randomised controlled trial (RCT). A total of 60 women between the ages of 18 years and 60 years who are experiencing refractory OAB will be randomly assigned to two groups: one receiving electroacupuncture and the other receiving conventional acupuncture. Each participant will undergo a treatment regimen lasting 4\u2009weeks. During the initial 2\u2009weeks, participants will receive five sessions of either electroacupuncture or conventional acupuncture per week, followed by three sessions per week during the subsequent 2\u2009weeks. In total, each individual will receive 16 treatment sessions throughout the course of the study. The primary outcome measure will be the change in OAB Symptom Score (OABSS) over time between groups. The secondary outcome measures will include the OABSS, the Patient-Perceived Bladder Symptom Grading Scale, the Overactive Bladder Questionnaire, the Self-Rating Anxiety Scale and the Self-Rating Depression Scale during the treatment and follow-up periods. Blinding and safety will also be assessed. Two-sided p values &lt;0.05\u2009will be considered statistically significant.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>The study protocol was approved by the Institutional Review Board of Beijing Fengtai Hospital of Integrated Traditional and Western Medicine on 5 February 2024 (Approval No. 2024020101). The results will be disseminated through presentations at scientific conferences and peer-reviewed publications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>ChiCTR2400081448.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-101864","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T10:05:40Z","timestamp":1752833140000},"page":"e101864","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of electroacupuncture for the treatment of refractory overactive bladder disease in women: study protocol for a randomised controlled clinical trial"],"prefix":"10.1136","volume":"15","author":[{"given":"Huai-Yu","family":"Wang","sequence":"first","affiliation":[{"name":"Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Ji","sequence":"additional","affiliation":[{"name":"Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, China"},{"name":"Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Chao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-9118","authenticated-orcid":false,"given":"Yulong","family":"Ding","sequence":"additional","affiliation":[{"name":"Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"2025101813142294000_15.7.e101864.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.038"},{"key":"2025101813142294000_15.7.e101864.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-002-0301-4"},{"key":"2025101813142294000_15.7.e101864.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.09.019"},{"key":"2025101813142294000_15.7.e101864.4","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.juro.2017.09.146","article-title":"Cross-Sectional Epidemiological Analysis of the Nagahama Study for Correlates of Overactive Bladder: Genetic and Environmental Considerations","volume":"199","author":"Funada","year":"2018","journal-title":"J Urol"},{"key":"2025101813142294000_15.7.e101864.5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41585-024-00967-8","article-title":"The mechanism of action of neuromodulation in the treatment of overactive bladder","volume":"22","author":"Krhut","year":"2025","journal-title":"Nat Rev Urol"},{"key":"2025101813142294000_15.7.e101864.6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/JU.0000000000004373","article-title":"Gene Therapy With URO-902 (pVAX\/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial","volume":"213","author":"Enemchukwu","year":"2025","journal-title":"J Urol"},{"key":"2025101813142294000_15.7.e101864.7","doi-asserted-by":"publisher","DOI":"10.1159\/000447205"},{"key":"2025101813142294000_15.7.e101864.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2009.07.1325"},{"key":"2025101813142294000_15.7.e101864.9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/luts.12304","article-title":"Current management of refractory overactive bladder","volume":"12","author":"Chen","year":"2020","journal-title":"Low Urin Tract Symptoms"},{"key":"2025101813142294000_15.7.e101864.10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/JU.0000000000000309","article-title":"Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA\/SUFU Guideline Amendment 2019","volume":"202","author":"Lightner","year":"2019","journal-title":"J Urol"},{"key":"2025101813142294000_15.7.e101864.11","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s12325-021-01650-9","article-title":"Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years\u2019 Experience and Future Directions","volume":"38","author":"van Ophoven","year":"2021","journal-title":"Adv Ther"},{"key":"2025101813142294000_15.7.e101864.12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/17434440.2022.2032655","article-title":"Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects","volume":"19","author":"Tilborghs","year":"2022","journal-title":"Expert Rev Med Devices"},{"key":"2025101813142294000_15.7.e101864.13","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/nau.24694","article-title":"Efficacy of sacral neuromodulation and percutaneous tibial nerve stimulation in the treatment of chronic nonobstructive urinary retention: A systematic review","volume":"40","author":"Ho","year":"2021","journal-title":"Neurourol Urodyn"},{"key":"2025101813142294000_15.7.e101864.14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1159\/000515991","article-title":"Mechanism and Priority of Botulinum Neurotoxin A versus Sacral Neuromodulation for Refractory Overactive Bladder: A Review","volume":"105","author":"Zhang","year":"2021","journal-title":"Urol Int"},{"key":"2025101813142294000_15.7.e101864.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006756","article-title":"Acupuncture for adults with overactive bladder: a systematic review protocol","volume":"5","author":"Mo","year":"2015","journal-title":"BMJ Open"},{"key":"2025101813142294000_15.7.e101864.16","doi-asserted-by":"publisher","DOI":"10.7326\/m21-1814"},{"key":"2025101813142294000_15.7.e101864.17","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017795","article-title":"Using electroacupuncture with optimized acupoint positioning to predict the efficacy of sacral neuromodulation of refractory overactive bladder: A case report","volume":"98","author":"Shen","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2025101813142294000_15.7.e101864.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2025101813142294000_15.7.e101864.19","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2010.1610"},{"key":"2025101813142294000_15.7.e101864.20","unstructured":"World Health Organization. Regional Office for the Western Pacific . WHO standard acupuncture point locations in the Western Pacific Region. Manila: World Health Organization Western Pacific Regional Office, 2008."},{"key":"2025101813142294000_15.7.e101864.21","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4067"},{"key":"2025101813142294000_15.7.e101864.22","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.985288","article-title":"Acupuncture for the treatment of overactive bladder: A systematic review and meta-analysis","volume":"13","author":"Lee","year":"2022","journal-title":"Front Neurol"},{"key":"2025101813142294000_15.7.e101864.23","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01205-z"},{"key":"2025101813142294000_15.7.e101864.24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.urology.2016.06.004","article-title":"Sacral Neuromodulation in Urological Practice","volume":"99","author":"Liberman","year":"2017","journal-title":"Urology"},{"key":"2025101813142294000_15.7.e101864.25","doi-asserted-by":"crossref","DOI":"10.1186\/s13020-020-00388-w","article-title":"A randomized controlled trial to assess the effectiveness and safety of acupuncture for overactive bladder: a study in Hong Kong population","volume":"15","author":"Lin","year":"2020","journal-title":"Chin Med"},{"key":"2025101813142294000_15.7.e101864.26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/0964528420925488","article-title":"Electroacupuncture for post-stroke overactive bladder: a multi-centre pilot randomized controlled trial","volume":"39","author":"Chen","year":"2021","journal-title":"Acupunct Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-101864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:14:33Z","timestamp":1760818473000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-101864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,18]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjopen-2025-101864"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-101864","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}